Skip to main content
Premium Trial:

Request an Annual Quote

Phase-1 in Toxicogenomics Service Partnership with NCI

NEW YORK, May 5 - Phase-1 Molecular Toxicology said today that it is providing toxicogenomics services for the National Cancer Institute.


Specifically, the company said it will analyze the toxicity of cancer treatments in comparison to the mechanism of antitumor action.


Phase-1 will receive animal tissues from several contract laboratories performing preclinical safety studies for the NCI and will evaluate the tissues for treatment-related gene expression effects.


According to Joseph Tomaszewski, chief of the toxicology and pharmacology branch at NCI, Phase-1 was chosen as NCI's service partner because "they have toxchips for the relevant species in which we perform our toxicity studies."

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.